Tatva Chintan Pharmatec vs Laxmi Organic Industries: Share Price, Comparison and Key Differences
- August 10, 2026
- Posted by: Lakshit Sharma
- Category: News
Tatva Chintan MCap Rs 4,060 Cr, PE 79.01x (thin earnings), ROE 5.38%, D/E 0.15. Laxmi Organic Industries MCap Rs 4,990 Cr, PE 39.74x, ROE 4.00%, D/E 0.27.
Tatva Chintan Pharmatec vs Laxmi Organic Industries is a comparison specialty organic chemical investors look up when evaluating two listed Indian specialty chemical companies. Tatva Chintan Pharmatec is a Vadodara-based company making structure-directing agents (SDAs) for zeolite synthesis, phase-transfer catalysts (PTCs) and specialty chemicals for pharma and agrochemical applications. Laxmi Organic Industries is a Mumbai-based company making specialty intermediates – particularly acetic acid derivatives, ethyl acetate and fluorochemical intermediates – for pharma, agro and food industries.
This Tatva Chintan Pharmatec vs Laxmi Organic Industries article covers reach and market position, key products, latest declared results and stock valuation. The Tatva Chintan Pharmatec vs Laxmi Organic Industries data below is sourced from Groww and public company filings and reflects the most recently available information at the time of writing.
Tatva Chintan Pharmatec vs Laxmi Organic Industries: Reach and Market Position
On the Tatva Chintan Pharmatec side of the Tatva Chintan Pharmatec vs Laxmi Organic Industries comparison, Tatva Chintan exports SDAs and PTCs to global zeolite and pharma manufacturers across the US, Europe and Japan. Market capitalisation is Rs 4,060 Cr.
Click Here – Get Free Investment Predictions
On the Laxmi Organic Industries side of the Tatva Chintan Pharmatec vs Laxmi Organic Industries comparison, Laxmi Organic produces ethyl acetate and acetaldehyde (commodity acetyl chain) and specialty fluorochemical intermediates. Market capitalisation is Rs 4,990 Cr.
Tatva Chintan Pharmatec vs Laxmi Organic Industries: Key Products and Business Mix
In the Tatva Chintan Pharmatec vs Laxmi Organic Industries product comparison, Tatva Chintan Pharmatec offers: Tatva Chintan earns from SDAs for zeolites, phase transfer catalysts, electrochemical salts and specialty pharma chemicals. EPS is Rs 21.97. PE is 79.01x, ROE 5.38 percent, D/E 0.15.
For Laxmi Organic Industries in this Tatva Chintan Pharmatec vs Laxmi Organic Industries breakdown: Laxmi Organic earns from ethyl acetate, acetaldehyde and specialty fluorochemicals. EPS is Rs 4.53. PE is 39.74x, ROE 4.00 percent, D/E 0.27.
Tatva Chintan Pharmatec vs Laxmi Organic Industries: Latest Results
The Tatva Chintan Pharmatec vs Laxmi Organic Industries results for Tatva Chintan Pharmatec: Tatva Chintan has a market cap of Rs 4,060 Cr and PE of 79.01x. ROE is 5.38 percent. Both companies are in a thin-earnings phase with low ROEs.
The Tatva Chintan Pharmatec vs Laxmi Organic Industries results for Laxmi Organic Industries: Laxmi Organic has a market cap of Rs 4,990 Cr and PE of 39.74x. ROE is 4.00 percent. Laxmi Organic is marginally larger and cheaper on PE, though both have thin ROE.
Compare Tatva Chintan Pharmatec and Laxmi Organic Industries Fundamentals on the Univest Screener
Tatva Chintan Pharmatec vs Laxmi Organic Industries: Stock and Valuation
The Tatva Chintan Pharmatec vs Laxmi Organic Industries stock comparison uses the latest available market data from Groww. Investors tracking Tatva Chintan Pharmatec vs Laxmi Organic Industries should verify current prices on NSE or BSE before trading.
Tatva Chintan vs Laxmi Organic Industries at current valuations: Tatva Chintan trades at Rs 4,060 Cr market cap, PE 79.01x, ROE 5.38 percent. Laxmi Organic trades at Rs 4,990 Cr market cap, PE 39.74x, ROE 4.00 percent. Both are similarly sized specialty organic companies with thin earnings. Laxmi is cheaper on PE; Tatva has a marginally higher ROE.
Tatva Chintan Pharmatec vs Laxmi Organic Industries: Quick Comparison Table
The Tatva Chintan Pharmatec vs Laxmi Organic Industries comparison table below summarises the key metrics covered in this article side by side.
| Parameter | Tatva Chintan Pharmatec | Laxmi Organic Industries |
|---|---|---|
| Sector | SDAs for zeolites + phase transfer catalysts + specialty pharma | Ethyl acetate + acetaldehyde + fluorochemical intermediates |
| Market Cap | Rs 4,060 Cr | Rs 4,990 Cr |
| P/E Ratio | 79.01x (thin earnings) | 39.74x |
| ROE | 5.38% | 4.00% |
| Debt to Equity | 0.15 | 0.27 |
| Key Clients | Global zeolite, pharma manufacturers | Pharma, agro, food (ethyl acetate consumers) |
| Dividend | 0.12% yield | 0.17% yield |
Conclusion
The Tatva Chintan Pharmatec vs Laxmi Organic Industries comparison above covers the key data points on reach, products, results and valuation. Tatva Chintan Pharmatec vs Laxmi Organic Industries covers two Indian specialty organic chemical companies with global export clients. Tatva Chintan has a unique SDA and PTC product range with limited global competition. Laxmi Organic has a large ethyl acetate business and a growing specialty fluorochemical segment. Tatva Chintan vs Laxmi Organic investors should review demand trends for zeolites, ethyl acetate pricing, fluorochemical investment progress and margin recovery. Tatva Chintan vs Laxmi Organic are both small specialty chemical stocks – consult a SEBI-registered advisor for personalised guidance.
Download the Univest iOS App or Univest Android App to track Tatva Chintan Pharmatec and Laxmi Organic Industries live price and get daily stock recommendations.
Disclaimer: Data and figures in this article are sourced from publicly available information, including company results filings and exchange data, and are current as of the time of writing. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is a structure-directing agent (SDA)?
Ans. An SDA (Structure-Directing Agent) is a quaternary ammonium compound used in the synthesis of zeolites – microporous crystalline materials used as molecular sieves in petroleum refining, petrochemicals and specialty catalysis. Tatva Chintan is a leading global SDA supplier.
What does Laxmi Organic make?
Ans. Laxmi Organic makes ethyl acetate (a solvent used in pharma, paints, printing inks and food), acetaldehyde and a growing portfolio of specialty fluorochemical intermediates for pharma and agrochem.
What is a phase transfer catalyst?
Ans. A phase transfer catalyst (PTC) is a chemical that enables reactions between reagents in different phases (e.g., water and organic solvent). Tatva Chintan’s PTCs are used in pharma API synthesis and agrochemical production.
Are both companies in a thin earnings phase?
Ans. Yes. Both Tatva Chintan and Laxmi Organic have thin ROEs (5 to 4 percent) and elevated PEs, reflecting the current challenging specialty chemical environment with Chinese competition and demand softness.
Are Tatva Chintan and Laxmi Organic in Nifty 50?
Ans. Neither is in Nifty 50. Both are tracked in smaller indices.
Which is larger, Tatva Chintan or Laxmi Organic?
Ans. Laxmi Organic (Rs 4,990 Cr) is marginally larger than Tatva Chintan (Rs 4,060 Cr).
Does Tatva Chintan pay dividends?
Ans. Yes. Tatva Chintan pays a small dividend yield of approximately 0.12 percent.